📣 VC round data is live. Check it out!
- Public Comps
- Hologic
Hologic Valuation Multiples
Discover Hologic's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Guardant Health, Zimmer Biomet, Sonova, United Imaging and more.
Hologic Overview
About Hologic
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Founded
1985
HQ

Employees
7.1K
Website
Financials (FY)
EV
$17B
Valuation Multiples
Start free trialHologic Stock Performance
Hologic has current market cap of $17B, and enterprise value of $17B.
Market Cap Evolution
Hologic's stock price is $75.65.
Hologic share price increased by 16.1% in the last year.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $17B | $17B | 0.0% | - | - | 16.1% | - |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHologic Valuation Multiples
Hologic Financial Valuation Multiples
As of June 2, 2026, Hologic has market cap of $17B and EV of $17B.
| LTM | Last FY | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hologic Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Hologic Competitors
Hologic competitors include Guardant Health, Zimmer Biomet, Sonova, United Imaging, Coloplast, Exact Sciences, Sartorius, Steris, Solventum and Fisher & Paykel.
Most Hologic public comparables operate across Medical Devices, Diagnostics & Genomics, BioTech, DeepTech, Longevity and FemTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 18.1x | 15.8x | (79.9x) | (87.5x) | |||
| 2.8x | 2.8x | 8.3x | 8.3x | |||
| 3.6x | 3.6x | 13.4x | 13.3x | |||
| 6.5x | 6.0x | 35.1x | 34.3x | |||
| - | 4.0x | - | 12.2x | |||
| - | - | - | - | |||
| 6.4x | 6.3x | 20.9x | 20.5x | |||
| 3.7x | 3.7x | 13.2x | 13.0x | |||
This data is available for Pro users. Sign up to see all Hologic competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Hologic
Hologic has acquired 11 companies to date.
Last acquisition by Hologic was on October 14th 2024. Hologic acquired Gynesonics for $350M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Hologic
| Description | Gynesonics is a Redwood City-headquartered medical device company focused on incisionless treatment for uterine fibroids. Its Sonata System uses ultrasound-guided radiofrequency ablation to shrink fibroids while preserving the uterus, serving women's health clinics in the United States and Europe. Gynesonics targets patients seeking alternatives to hysterectomy or myomectomy. | Endomag is a medical technology company headquartered in Cambridge, United Kingdom. It manufactures magnetic localization products including the Sentimag probe, Magseed marker, and Magtrac node marker used in breast cancer surgeries worldwide. These devices enable precise sentinel lymph node biopsies and tumor marking, reducing unnecessary procedures for over 100,000 women since 2019. Acquired by Hologic in 2021, Endomag distributes its platform across Europe, the Middle East, Africa, and Australasia through a network of partners. Originally spun out from the University of Houston and University College London in 2007, it supports leading cancer centers in delivering less invasive care. | Bolder Surgical is a medical device company that manufactures minimally invasive laparoscopic instruments for accessing hard-to-reach anatomical structures. Its product line includes the Platax articulating needle driver and the Frecce scissors, used in gynecological, urological, and general surgeries. Louisville-based and founded in 2010, the firm holds over 20 patents and supplies tools to hospitals in North America and Europe. In 2023, Bolder Surgical expanded its portfolio with the launch of single-use devices certified under ISO 13485 standards. | Mobidiag is a Keilaranta-headquartered Finnish-French biotechnology company offering qPCR and microarray tests for gastrointestinal infections, antibiotic resistance, HAIs, respiratory pathogens, and sepsis. Its automated platforms like Novodiag serve labs from small clinics to high-volume centers across Europe and beyond. | |
| HQ Country | |||||
| HQ City | San Francisco, CA | Cambridge | Boulder, CO | Espoo | |
| Deal Date | 14 Oct 2024 | 29 Apr 2024 | 14 Oct 2021 | 8 Apr 2021 | |
| Valuation | $350M | $310M | $160M | $808M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Hologic acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Investments by Hologic
Hologic has invested in 1 company to date.
Latest investment by Hologic was on September 3rd 2025. Hologic invested in Mercy BioAnalytics in their $59M Series B round (EV/Revenue multiple available to Pro users).
Latest Investments by Hologic
| Description | Mercy BioAnalytics is a diagnostics company developing blood tests for early-stage cancer detection using extracellular vesicles. Its platform analyzes EV biomarkers from liquid biopsies to identify stage I tumors in lung and breast cancers. Natick-headquartered since 2018, Mercy BioAnalytics collaborates with Mayo Clinic for clinical validation and plans FDA submissions in 2024. |
| HQ Country | |
| HQ City | Boston, MA |
| Deal Date | 3 Sep 2025 |
| Round | Series B |
| Raised | $59M |
| Investors | Avestria Ventures; BrightEdge (American Cancer Society VC unit); Bruker; Hologic; iSelect Fund; Labcorp; Mindshift Capital; Novalis LifeSciences; Perceptive Xontogeny Venture Fund; Portfolia; Sozo Ventures |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Hologic investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hologic
| When was Hologic founded? | Hologic was founded in 1985. |
| Where is Hologic headquartered? | Hologic is headquartered in United States. |
| How many employees does Hologic have? | As of today, Hologic has over 7K employees. |
| Who is the CEO of Hologic? | Hologic's CEO is Stephen P. Macmillan. |
| Is Hologic publicly listed? | Yes, Hologic is a public company listed on Berlin Stock Exchange. |
| What is the stock symbol of Hologic? | Hologic trades under HO1 ticker. |
| When did Hologic go public? | Hologic went public in 1990. |
| Who are competitors of Hologic? | Hologic main competitors include Guardant Health, Zimmer Biomet, Sonova, United Imaging, Coloplast, Exact Sciences, Sartorius, Steris, Solventum, Fisher & Paykel. |
| What is the current market cap of Hologic? | Hologic's current market cap is $17B. |
| Is Hologic profitable? | No, Hologic is not profitable. |
| How many companies Hologic has acquired to date? | As of June 2026, Hologic has acquired 11 companies. |
| What was the largest acquisition by Hologic? | $2B acquisition of Cynosure on 14th February 2017 was the largest M&A Hologic has done to date. |
| What companies Hologic acquired? | Hologic acquired Cynosure, Mobidiag, Gynesonics, Endomag, Biotheranostics, Bolder Surgical, Diagenode, Focal Therapeutics, Faxitron Bioptics, Acessa Health, and 1 other company. |
| In how many companies Hologic has invested to date? | As of June 2026, Hologic has invested in 1 company. |
| What was the last Hologic investment? | On 3rd September 2025 Hologic invested in Mercy BioAnalytics, participating in a $59M Series B round, alongside Avestria Ventures, BrightEdge (American Cancer Society VC unit), Bruker, iSelect Fund, Labcorp, Mindshift Capital, Novalis LifeSciences, Perceptive Xontogeny Venture Fund, Portfolia, and Sozo Ventures. |
| In what companies Hologic invested in? | Hologic invested in Mercy BioAnalytics. |
See public comps similar to Hologic
Lists including Hologic
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.


